David Mott
Chairman bij ADAPTIMMUNE THERAPEUTICS PLC
Vermogen: 12 M $ op 31-03-2024
Oorsprong van het eerstegraads netwerk van David Mott
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers.
210
| Non-Profit Organization | Miscellaneous Commercial Services | 210 |
NEA Management Co. LLC
 NEA Management Co. LLC Investment ManagersFinance New Enterprise Associates LLC (New Enterprise Associates) is a venture capital firm founded in 1977. The firm headquartered in Menlo Park, California.
96
| Holding Company | Investment Managers | 96 |
MedImmune LLC
 MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD.
73
| Subsidiary | Biotechnology | 73 |
| Subsidiary | Biotechnology | 55 | |
Dartmouth College
49
| College/University | Other Consumer Services | 49 |
| Public Company | Biotechnology | 41 | |
| Public Company | Biotechnology | 38 | |
34
| Subsidiary | Pharmaceuticals: Major | 34 |
| Public Company | Pharmaceuticals: Major | 32 | |
| Public Company | Biotechnology | 32 | |
Smith Barney Harris Upham & Co., Inc.
21
| Extinct | Investment Banks/Brokers | 21 |
MedImmune Ltd.
 MedImmune Ltd. BiotechnologyHealth Technology MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom.
15
| Subsidiary | Biotechnology | 15 |
| Subsidiary | Pharmaceuticals: Major | 15 | |
| Public Company | Pharmaceuticals: Major | 13 | |
9
| Subsidiary | Pharmaceuticals: Major | 9 |
| Extinct | Biotechnology | 8 | |
Complexa, Inc.
 Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA.
7
| Private Company | Pharmaceuticals: Major | 7 |
MedImmune Ventures, Inc.
 MedImmune Ventures, Inc. Investment ManagersFinance MedImmune Ventures, Inc. ( Medimmune Ventures) is a venture capital firm founded in 2002 by Ron Laufer, Wayne Hockmeyer and David Mott . The firm is headquartered in Gaithersburg, Maryland.
7
| Subsidiary | Investment Managers | 7 |
Omthera Pharmaceuticals, Inc.
 Omthera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Omthera Pharmaceuticals, Inc. operates as pharmaceuticals company which focuses on the clinical development of new therapies for dyslipidemia. The company was founded by Jerry Wisler and Michael Davidson in 2008 and is headquartered in Princeton, NJ.
4
| Subsidiary | Pharmaceuticals: Major | 4 |
New Enterprise Associates LLC
 New Enterprise Associates LLC Investment ManagersFinance New Enterprise Associates LLC is an alternative investment manager. The private company is based in Timonium, MD. The company was founded in 1978 by Chuck Newhall, C. Richard Kramlich.
4
| Private Company | Investment Managers | 4 |
Tiburio Therapeutics, Inc.
 Tiburio Therapeutics, Inc. BiotechnologyHealth Technology Tiburio Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It provides novel treatments for rare neuroendocrine tumors and endocrine diseases. The company was founded by James Gregg McArthur in January 2019 and is headquartered in Cambridge, MA.
4
| Holding Company | Biotechnology | 4 |
Cydan LLC
 Cydan LLC Medical DistributorsDistribution Services Cydan LLC operates as an orphan drug accelerator that identifies and de-risks programs. The firm's model evaluates programs for treating rare diseases with unmet medical need and is aimed at creating new companies to develop those therapies. The company was founded by James G. McArthur in 2013 and is headquartered in Cambridge, MA.
4
| Subsidiary | Medical Distributors | 4 |
XTuit Pharmaceuticals, Inc.
 XTuit Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology XTuit Pharmaceuticals, Inc. develops drugs for the treatment of cancer. The firm develops pharmaceutical products for use in the diagnosis and treatment of oncological, tumor and inflammatory diseases. The company was founded by Alan L. Crane, Rakesh Kumar Jain, Andrew Werk Cook, Edwin L. Steele, David H. Koch, Ronald Evans, Howard Hughes and Robert S. Langer, Jr. in 2011 and is headquartered in Waltham, MA.
4
| Holding Company | Pharmaceuticals: Major | 4 |
| Subsidiary | Pharmaceuticals: Major | 2 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met David Mott via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member | |
| AMGEN INC. | Pharmaceuticals: Major | Chief Operating Officer Private Equity Investor Sales & Marketing Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| BAXTER INTERNATIONAL INC. | Medical Specialties | Chief Tech/Sci/R&D Officer Director/Board Member Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing Chief Tech/Sci/R&D Officer | |
| GILEAD SCIENCES, INC. | Biotechnology | Chief Executive Officer Sales & Marketing | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Sales & Marketing Chief Tech/Sci/R&D Officer Chief Operating Officer Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Private Equity Investor Corporate Officer/Principal Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Chief Executive Officer Sales & Marketing Private Equity Analyst Corporate Officer/Principal Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal Director of Finance/CFO Corporate Officer/Principal | |
| IONIS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Operating Officer | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| MOMENTA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Founder General Counsel | |
| ULTRAGENYX PHARMACEUTICAL INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| RENOVARO INC. | Biotechnology | Director/Board Member Director/Board Member | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| Stanford University | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
| University of Oxford | College/University | Undergraduate Degree Undergraduate Degree Graduate Degree | |
Adaptimmune Ltd.
 Adaptimmune Ltd. Medical/Nursing ServicesHealth Services Adaptimmune Ltd. develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases. It utilizes the T cell to target and destroy cancerous and infected cells by using affinity T cell receptor proteins as a means of strengthening patient T cell responses. The company was founded by Bent K. Jakobsen, James Julian Noble and Helena Katrina Tayton-Martin in 2008 and is headquartered in Oxford, the United Kingdom. | Medical/Nursing Services | Corporate Secretary Founder Director/Board Member Founder Director/Board Member | |
| Yale University | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
| SAGIMET BIOSCIENCES INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Vtesse, Inc.
 Vtesse, Inc. BiotechnologyHealth Technology Vtesse, Inc. provides novel drugs for life-threatening rare diseases. It developed VTS-270, a modified form of cyclodextrin that has been evaluated in preclinical and clinical studies at institutes within the National Institutes of Health (NIH) to treat patients with Niemann-Pick Disease Type C (NPC). The firm is working with the NIH and other leading academic centers to advance clinical study of VTS-270 for NPC, and to conduct pre-clinical discovery and development of other novel drugs for NPC and other LSDs. The company was founded by Ben Machielse in 2015 and is headquartered in Gaithersburg, MD. | Biotechnology | Director/Board Member Director/Board Member Founder Director/Board Member | |
| GLYCOMIMETICS, INC. | Pharmaceuticals: Major | Director/Board Member Founder Chairman | |
| Massachusetts Institute of Technology | College/University | Corporate Officer/Principal Graduate Degree Graduate Degree | |
| XILIO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member President Corporate Officer/Principal | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| The University of Chicago | College/University | Doctorate Degree Doctorate Degree Masters Business Admin | |
| IOMAI CORPORATION | Biotechnology | Director/Board Member Chief Executive Officer Director/Board Member | |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Comptroller/Controller/Auditor Corporate Officer/Principal Corporate Officer/Principal | |
Learning Undefeated, Inc.
 Learning Undefeated, Inc. Investment Trusts/Mutual FundsMiscellaneous Learning Undefeated, Inc. is a non-profit organization that provides STEM education opportunities for underserved communities. The non-profit company is based in Gaithersburg. The American company's flagship education program features mobile STEM labs that have provided hands-on learning opportunities to more than 200,000 K-12 students in 18 states since 2003. The company also operates several other celebrated STEM education programs including the Young Science Explorers program, a summer camp for middle school students, and the Advancing Tomorrow's Leaders in STEM (ATLAS) college and career exploration program. Learning Undefeated is driving race and gender equity in STEM through experiential and deep-impact learning experiences for students from under-resourced communities. | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member Chairman | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
New York Biotechnology Association, Inc.
 New York Biotechnology Association, Inc. Miscellaneous Commercial ServicesCommercial Services New York Biotechnology Association, Inc. promotes the biotechnology industry. It supports the development and growth of New York State''s life science industry, and serves its members and the life science community by providing a network for public policy, industry advocacy, and community development. The company is headquartered in New York, NY. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Chairman | |
| University of Cambridge | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| AMAG PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Compliance Officer | |
| London Business School | College/University | Chairman Masters Business Admin Masters Business Admin | |
| Stanford Law School | College/University | Graduate Degree Graduate Degree Graduate Degree | |
| ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The private company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
NightstaRx Ltd.
 NightstaRx Ltd. Medical/Nursing ServicesHealth Services NightstaRx Ltd. develops and commercializes therapies for retinal dystrophies. It offers retinal gene therapy that provides one-time cure for choroideremia (a rare inherited cause of blindness) and other retinal dystrophies. The company was founded by Robert MacLaren, Miguel Seabra, and Matthew During in January 2014 and is headquartered in London, the United Kingdom. | Medical/Nursing Services | Director/Board Member Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 43 |
| Verenigd Koninkrijk | 7 |
| Denemarken | 2 |
| Japan | 2 |
Sectoraal
| Health Technology | 33 |
| Consumer Services | 12 |
| Commercial Services | 4 |
| Health Services | 3 |
| Finance | 2 |
Operationeel
| Director/Board Member | 811 |
| Corporate Officer/Principal | 262 |
| Independent Dir/Board Member | 226 |
| Chairman | 137 |
| Chief Executive Officer | 118 |
Sterkste connecties
| Insiders | |
|---|---|
| Robert Langer | 88 |
| Annalisa Jenkins | 51 |
| Beth Seidenberg | 39 |
| James Noble | 39 |
| Carol Gallagher | 39 |
| John Maraganore | 37 |
| Barbara Dalton | 35 |
| Ali Behbahani | 34 |
| Lonnie Moulder | 31 |
| Mette Agger | 30 |
| Steven Holtzman | 28 |
| David Pyott | 27 |
| James Sapirstein | 26 |
| Gary Evans | 25 |
| Jason Rhodes | 24 |
- Beurs
- Insiders
- David Mott
- Bedrijfsconnecties
